gynsm,ADC,oncology,MedTwitter – MashupMD

Mashup Score: 9

Tisotumab Vedotin Boosts Survival in Chinese Subpopulation With Previously Treated Cervical Cancer - 8 hour(s) ago

Tisotumab vedotin led to improved survival vs chemotherapy in a Chinese subpopulation of previously treated cervical cancer enrolled in innovaTV 301.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Treatment with tisotumab vedotin-tftv led to improved OS vs chemotherapy in a Chinese subpopulation of patients with previously treated, recurrent or metastatic cervical cancer enrolled in the phase 3 innovaTV 301 study. #gynsm #ADC #oncology #MedTwitter https://t.co/7ryYxc81bo https://t.co/XTPzqBdPdE

Mashup Score: 20

Tisotumab Vedotin Boosts Survival in Chinese Subpopulation With Previously Treated Cervical Cancer - 2 day(s) ago

Tisotumab vedotin led to improved survival vs chemotherapy in a Chinese subpopulation of previously treated cervical cancer enrolled in innovaTV 301.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Treatment with tisotumab vedotin-tftv led to improved OS vs chemotherapy in a Chinese subpopulation of patients with previously treated, recurrent or metastatic cervical cancer enrolled in the phase 3 innovaTV 301 study. #gynsm #ADC #oncology #MedTwitter https://t.co/7ryYxc81bo https://t.co/XTPzqBdPdE